InvestorsHub Logo
Followers 73
Posts 6235
Boards Moderated 0
Alias Born 05/01/2011

Re: Chemist2 post# 160464

Saturday, 11/17/2018 2:57:01 PM

Saturday, November 17, 2018 2:57:01 PM

Post# of 429278
No, and if the trial continues after the 75% interim look, we might not see that PRed either...

Amarin has one drug under development right now. Everything is material for that to the company. AZN is huge and has a zillion drugs under development -- an interim look for one trial isn't material, and so they have no requirement to PR that.

The end of the trial would be material -- that they would have to disclose. Good end or bad end.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News